Journal of the National Cancer Institute Advance Access originally published online on January 29, 2008
JNCI Journal of the National Cancer Institute 2008 100(3):162-169; doi:10.1093/jnci/djn007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2008.
NEWS |
Chemobrain Is Real but May Need New Name
| The first 150 words of the full text of this article appear below. |
Cancer patients know that chemobrain is real. The nearly ubiquitous experience of foggy thinking immediately after chemotherapy treatment has even inspired T-shirts and buttons emblazoned with "My Name is Chemo Brain." For some cancer survivors, the cognitive effects of chemotherapy such as lack of concentration and short-term memory loss linger for years after treatment, but little is known about who is most likely to suffer a long-term deficit or how to guard against it. Confounding factors such as fatigue and depression—as well as widely divergent patient experiences—have made studying the cognitive consequences of chemotherapy problematic. That obstacle has led to a disconnect between patient experiences and physician attention to the issue.
"I think it's probably true that there's still a fair amount of skepticism amongst some people about how real of a phenomenon this is," says Tim Ahles, Ph.D., a cognitive psychologist at Memorial Sloan-Kettering Cancer Center in New York.
Should It Be "Cancer Brain"?
Organizing the Field
Lessening the Effects
Survey Points to Doctor–Patient Miscommunication in Chemobrain Research
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T.-H. Kang, J. T. Reardon, M. Kemp, and A. Sancar From the Cover: Circadian oscillation of nucleotide excision repair in mammalian brain PNAS, February 24, 2009; 106(8): 2864 - 2867. [Abstract] [Full Text] [PDF]
|
|